Application of Megavoltage Imaging to Reduce Artifact After Seed Implants
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Prostate Cancer
Related studies linked through entity extraction aliases.
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer
- Status
- COMPLETED
- Phase
- NA
Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
Focal Therapy for Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Tumor TARGET Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Autologous Natural Killer T Cells Infusion for the Treatment of Cancer
- Status
- UNKNOWN
- Phase
- NA
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of VTI Doppler Probe Use to Identify Neurovascular Bundle During Prostate Surgery
- Status
- TERMINATED
- Phase
- NA
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
- Status
- COMPLETED
- Phase
- PHASE4
Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples
- Status
- WITHDRAWN
- Phase
- N/A
Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in Humans
- Status
- COMPLETED
- Phase
- PHASE1
The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1